Researchers published in Science that used AI-guided design to partially eliminate isoleucine usage in engineered Escherichia coli ribosome proteins by substituting alternatives across dozens of proteins. The work frames a test of whether life could function with fewer canonical amino acids, and it also demonstrates an AI approach to protein-structure prediction and redesign. While the modified bacteria are not presented as an immediate therapeutic platform, the strategy could inform protein engineering workflows where stability or function is tuned through changes to amino-acid composition. The findings also add a new direction for synthetic genomes engineering by showing that targeting constraints at the ribosome level—where amino acid elimination is described as especially difficult—can still yield viable designs. The research community will likely focus on how far the system can be pushed toward broader amino-acid reduction and what kinds of bespoke proteins or production advantages could follow from this design framework.